Cover Image
Market Research Report

ASIA PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2018 -2026

Published by Inkwood Research Product code 618284
Published Content info 92 Pages
Delivery time: 2-3 business days
Price
Back to Top
ASIA PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2018 -2026
Published: March 26, 2018 Content info: 92 Pages
Description

KEY FINDINGS

Over the projected years of 2018-2026, the Asia Pacific cardiovascular ultrasound system market is forecasted to showcase the highest CAGR of 6.24%. Factors like growing incidences of cardiovascular diseases and growing demand for minimally invasive procedures are driving the market growth in this region.

MARKET INSIGHTS

The Asia-Pacific cardiovascular ultrasound system market is segmented on the basis of technologies, test-type and display device. Presently, the 2D ultrasound technology dominates this region while stress echocardiogram and black and white display captured a significant share of test-type and display segment in 2017. The China vascular ultrasound market is expected to showcase a significant CAGR rise over the forecast period. However, the high cost of surgeries and unfavourable reimbursement policies could restrain the market growth considerably.

COMPETITIVE INSIGHTS

Ge Healthcare Inc, Hitachi Medical Corporation, Samsung Electronics Co. Ltd, Toshiba Medical Systems Corporation, Abbott Vascular Inc, Fujifilm Holdings Corporation, Philips Healthcare, Atricure Inc, Esaote S.P.A, Stryker Corporation and Mindray Medical International Limited are eminent players operating in this market.

Table of Contents
Product Code: 16317

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. CONTINUOUS INNOVATION IN CARDIAC ULTRASOUND SYSTEMS
    • 3.2.2. 2D CARDIOVASCULAR ULTRASOUND SYSTEM IS A LEADING TECHNOLOGY
    • 3.2.3. HOSPITALS AND CARDIOLOGY CENTERS ARE THE MARKET LEADERS IN TERMS OF END USERS

4. MARKET DETERMINANTS

  • 4.1. MARKET DRIVERS
    • 4.1.1. ESCALATING PREVALENCE OF CARDIOVASCULAR DISEASES
    • 4.1.2. GROWING HEALTHCARE EXPENDITURE
    • 4.1.3. ADVANCES IN TECHNOLOGY
    • 4.1.4. GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
  • 4.2. MARKET RESTRAINTS
    • 4.2.1. HIGH COST OF SURGERIES
    • 4.2.2. GROWING IMPLEMENTATION OF NOVEL AND ALTERNATIVE TECHNOLOGIES
    • 4.2.3. UNFAVOURABLE REIMBURSEMENT POLICY
  • 4.3. MARKET OPPORTUNITIES
    • 4.3.1. INCREASE IN THE RESEARCH AND DEVELOPMENT
    • 4.3.2. RISING MINIATURE MODELS OF ULTRASOUND MACHINES DUE TO RAPIDLY GROWING DEMAND OF MOBILE BASED ULTRASOUND DEVICES
  • 4.4. MARKET CHALLENGES
    • 4.4.1. HIGH COST OF INTERVENTIONAL CARDIOLOGY PROCEDURES
    • 4.4.2. COMPLICATIONS ASSOCIATED WITH THE USAGE OF INTERVENTIONAL CARDIOLOGY DEVICES

5. MARKET SEGMENTATION

  • 5.1. MARKET BY TEST TYPE 2018-2026
    • 5.1.1. TRANSTHORACIC ECHOCARDIOGRAM
    • 5.1.2. TRANSESOPHAGEAL ECHOCARDIOGRAM
    • 5.1.3. STRESS ECHOCARDIOGRAM
    • 5.1.4. OTHER ECHOCARDIOGRAM
  • 5.2. MARKET BY TECHNOLOGY 2018-2026
    • 5.2.1. 2D ULTRASOUND
    • 5.2.2. 3D & 4D ULTRASOUND
    • 5.2.3. DOPPLER IMAGING
  • 5.3. MARKET BY DISPLAY DEVICE 2018-2026
    • 5.3.1. COLOUR DISPLAY
    • 5.3.2. BLACK & WHITE DISPLAY
  • 5.4. MARKET BY END USER 2018-2026
    • 5.4.1. HOSPITAL & CARDIOLOGY CENTERS
    • 5.4.2. HOME & AMBULATORY CARE SETTINGS
    • 5.4.3. OTHER END USERS

6. KEY ANALYTICS

  • 6.1. PORTER'S FIVE FORCES MODEL
    • 6.1.1. BARGAINING POWER OF BUYER
    • 6.1.2. BARGAINING POWER OF SUPPLIER
    • 6.1.3. INTENSITY OF COMPETITIVE RIVALRY
    • 6.1.4. THREATS OF NEW ENTRANTS
    • 6.1.5. THREAT OF SUBSTITUTE PRODUCTS
  • 6.2. VALUE CHAIN ANALYSIS
    • 6.2.1. SUPPLIERS
    • 6.2.2. MANUFACTURERS
    • 6.2.3. DISTRIBUTORS & RETAILERS
    • 6.2.4. END USERS
  • 6.3. MARKET ANALYSIS
    • 6.3.1. PARENT MARKET ANALYSIS
    • 6.3.2. SUBSTITUTE MARKET
  • 6.4. KEY BUYING CRITERIA
    • 6.4.1. QUALITY
    • 6.4.2. PRICE
    • 6.4.3. PORTABILITY
    • 6.4.4. AVAILABILITY
    • 6.4.5. TECHNOLOGY & INNOVATIONS
    • 6.4.6. SUCCESS RATE
  • 6.5. REGULATORY FRAMEWORK

7. GEOGRAPHICAL ANALYSIS

  • 7.1. ASIA PACIFIC
    • 7.1.1. INDIA
    • 7.1.2. CHINA
    • 7.1.3. JAPAN
    • 7.1.4. SOUTH KOREA
    • 7.1.5. AUSTRALIA
    • 7.1.6. REST OF APAC

8. COMPANY PROFILES

  • 8.1. COMPETITIVE ANALYSIS
    • 8.1.1. MARKET SHARE ANALYSIS
    • 8.1.2. TOP COMPANIES
    • 8.1.3. KEY COMPANY STRATEGIES
      • 8.1.3.1. MERGER & ACQUISITION
      • 8.1.3.2. COLLABORATION& PARTNERSHIP
      • 8.1.3.3. LAUNCH OF PRODUCTS
  • 8.2. ABBOTT VASCULAR INC.
    • 8.2.1. COMPANY OVERVIEW
    • 8.2.2. PRODUCT PORTFOLIO
    • 8.2.3. STRATEGIC INITIATIVES
    • 8.2.4. SCOT ANALYSIS
  • 8.3. ATRICURE INC
    • 8.3.1. COMPANY OVERVIEW
    • 8.3.2. PRODUCT PORTFOLIO
    • 8.3.3. STRATEGIC INITIATIVES
    • 8.3.4. SWOT ANALYSIS
  • 8.4. BOSTON SCIENTIFIC CORPORATION
    • 8.4.1. COMPANY OVERVIEW
    • 8.4.2. PRODUCT PORTFOLIO
    • 8.4.3. STRATEGIC INITIATIVES
    • 8.4.4. SWOT ANALYSIS
  • 8.5. CHISON MEDICAL IMAGING CO. LTD.
    • 8.5.1. COMPANY OVERVIEW
    • 8.5.2. PRODUCT PORTFOLIO
    • 8.5.3. STRATEGIC INITIATIVE
    • 8.5.4. SCOT ANALYSIS
  • 8.6. ESAOTE S.P.A
    • 8.6.1. COMPANY OVERVIEW
    • 8.6.2. PRODUCT PORTFOLIO
    • 8.6.3. STRATEGIC ANALYSIS
    • 8.6.4. SCOT ANALYSIS
  • 8.7. FUJIFILM HOLDINGS CORPORATION
    • 8.7.1. COMPANY OVERVIEW
    • 8.7.2. PRODUCT PORTFOLIO
    • 8.7.3. STRATEGIC INITIATIVES
    • 8.7.4. SCOT ANALYSIS
  • 8.8. GE HEALTHCARE INC.
    • 8.8.1. COMPANY OVERVIEW
    • 8.8.2. PRODUCT PORTFOLIO
    • 8.8.3. STRATEGY INITIATIVES
    • 8.8.4. SCOT ANALYSIS
  • 8.9. HITACHI MEDICAL CORPORATION
    • 8.9.1. COMPANY OVERVIEW
    • 8.9.2. PRODUCTS PORTFOLIO
    • 8.9.3. SCOT ANALYSIS
  • 8.10. MINDRAY MEDICAL INTERNATIONAL LIMITED
    • 8.10.1. COMPANY OVERVIEW
    • 8.10.2. PRODUCT PORTFOLIO
    • 8.10.3. STRATEGIC INITIATIVES
    • 8.10.4. SCOT ANALYSIS
  • 8.11. PHILIPS HEALTHCARE
    • 8.11.1. COMPANY OVERVIEW
    • 8.11.2. PRODUCT PORTFOLIO
    • 8.11.3. STRATEGIC INITIATIVES
    • 8.11.4. SCOT ANALYSIS
  • 8.12. SAMSUNG ELECTRONICS CO. LTD.
    • 8.12.1. COMPANY OVERVIEW
    • 8.12.2. PRODUCT PORTFOLIO
    • 8.12.3. STRATEGIC INITIATIVE
    • 8.12.4. SCOT ANALYSIS
  • 8.13. STRYKER CORPORATION
    • 8.13.1. COMPANY OVERVIEW
    • 8.13.2. PRODUCTS PORTFOLIO
    • 8.13.3. SCOT ANALYSIS
  • 8.14. TOSHIBA MEDICAL SYSTEMS CORPORATION (ACQUIRED BY CANON INC.)
    • 8.14.1. COMPANY OVERVIEW
    • 8.14.2. PRODUCT PORTFOLIO
    • 8.14.3. STRATEGIC INITIATIVES
    • 8.14.4. SWOT ANALYSIS
  • 8.15. ULTRASOUND TECHNOLOGIES LTD.
    • 8.15.1. COMPANY OVERVIEW
    • 8.15.2. PRODUCT PORTFOLIO
    • 8.15.3. SCOT ANALYSIS
  • 8.16. UNETIXS VASCULAR INC. (ACQUIRED BY OPTO CIRCUITS)
    • 8.16.1. COMPANY OVERVIEW
    • 8.16.2. PRODUCT PORTFOLIO
    • 8.16.3. STRATEGIC INITIATIVES
    • 8.16.4. SCOT ANALYSIS

TABLE LIST

  • TABLE 1 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2018 -2026 ($ MILLION)
  • TABLE 3 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET BY TEST TYPES 2018-2026 ($ MILLION)
  • TABLE 4 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN TRANSTHORACIC ECHOCARDIOGRAM 2018-2026 ($ MILLION)
  • TABLE 5 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN TRANSESOPHAGEAL ECHOCARDIOGRAM 2018-2026 ($ MILLION)
  • TABLE 6 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN STRESS ECHOCARDIOGRAM 2018-2026 ($ MILLION)
  • TABLE 7 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN OTHER ECHOCARDIOGRAM 2018-2026 ($ MILLION)
  • TABLE 8 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)
  • TABLE 9 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN 2D ULTRASOUND 2018-2026 ($ MILLION)
  • TABLE 10 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN 3D & 4D ULTRASOUND 2018-2026 ($ MILLION)
  • TABLE 11 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN DOPPLER IMAGING 2018-2026 ($ MILLION)
  • TABLE 12 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET BY DISPLAY DEVICE 2018-2026 ($ MILLION)
  • TABLE 13 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN COLOUR DISPLAY 2018-2026 ($ MILLION)
  • TABLE 14 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN BLACK & WHITE DISPLAY 2018-2026 ($ MILLION)
  • TABLE 15 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET BY END USERS 2018-2026 ($ MILLION)
  • TABLE 16 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN HOSPITAL & CARDIOLOGY CENTERS 2018-2026 ($ MILLION)
  • TABLE 17 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN HOME & AMBULATORY CARE SETTINGS 2018-2026 ($ MILLION)
  • TABLE 18 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN OTHER END USERS 2018-2026 ($ MILLION)
  • TABLE 19 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET 2018-2026 ($ MILLION)
  • TABLE 59 INDIA CARDIOVASCULAR ULTRASOUND MARKET BY TEST TYPE 2018-2026 ($ MILLION)
  • TABLE 60 INDIA CARDIOVASCULAR ULTRASOUND MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)
  • TABLE 61 INDIA CARDIOVASCULAR ULTRASOUND MARKET BY DISPLAY DEVICE 2018-2026 ($ MILLION)
  • TABLE 62 INDIA CARDIOVASCULAR ULTRASOUND MARKET BY END USER 2018-2026 ($ MILLION)
  • TABLE 63 CHINA CARDIOVASCULAR ULTRASOUND MARKET BY TEST TYPE 2018-2026 ($ MILLION)
  • TABLE 64 CHINA CARDIOVASCULAR ULTRASOUND MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)
  • TABLE 65 CHINA CARDIOVASCULAR ULTRASOUND MARKET BY DISPLAY DEVICE 2018-2026 ($ MILLION)
  • TABLE 66 CHINA CARDIOVASCULAR ULTRASOUND MARKET BY END USER 2018-2026 ($ MILLION)
  • TABLE 67 JAPAN CARDIOVASCULAR ULTRASOUND MARKET BY TEST TYPE 2018-2026 ($ MILLION)
  • TABLE 68 JAPAN CARDIOVASCULAR ULTRASOUND MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)
  • TABLE 69 JAPAN CARDIOVASCULAR ULTRASOUND MARKET BY DISPLAY DEVICE 2018-2026 ($ MILLION)
  • TABLE 70 JAPAN CARDIOVASCULAR ULTRASOUND MARKET BY END USER 2018-2026 ($ MILLION)
  • TABLE 71 SOUTH KOREA CARDIOVASCULAR ULTRASOUND MARKET BY TEST TYPE 2018-2026 ($ MILLION)
  • TABLE 72 SOUTH KOREA CARDIOVASCULAR ULTRASOUND MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)
  • TABLE 73 SOUTH KOREA CARDIOVASCULAR ULTRASOUND MARKET BY DISPLAY DEVICE 2018-2026 ($ MILLION)
  • TABLE 74 SOUTH KOREA CARDIOVASCULAR ULTRASOUND MARKET BY END USER 2018-2026 ($ MILLION)
  • TABLE 75 AUSTRALIA CARDIOVASCULAR ULTRASOUND MARKET BY TEST TYPE 2018-2026 ($ MILLION)
  • TABLE 76 AUSTRALIA CARDIOVASCULAR ULTRASOUND MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)
  • TABLE 77 AUSTRALIA CARDIOVASCULAR ULTRASOUND MARKET BY DISPLAY DEVICE 2018-2026 ($ MILLION)
  • TABLE 78 AUSTRALIA CARDIOVASCULAR ULTRASOUND MARKET BY END USER 2018-2026 ($ MILLION)
  • TABLE 79 REST OF APAC CARDIOVASCULAR ULTRASOUND MARKET BY TEST TYPE 2018-2026 ($ MILLION)
  • TABLE 80 REST OF APAC CARDIOVASCULAR ULTRASOUND MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)
  • TABLE 81 REST OF APAC CARDIOVASCULAR ULTRASOUND MARKET BY DISPLAY DEVICE 2018-2026 ($ MILLION)
  • TABLE 82 REST OF APAC CARDIOVASCULAR ULTRASOUND MARKET BY END USER 2018-2026 ($ MILLION)
  • FIGURES LIST
  • FIGURE 1 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2018 -2026 ($ MILLION)
  • FIGURE 2 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN TRANSTHORACIC ECHOCARDIOGRAM 2018-2026 ($ MILLION)
  • FIGURE 3 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN TRANSESOPHAGEAL ECHOCARDIOGRAM 2018-2026 ($ MILLION)
  • FIGURE 4 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN STRESS ECHOCARDIOGRAM 2018-2026 ($ MILLION)
  • FIGURE 5 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN OTHER ECHOCARDIOGRAM 2018-2026 ($ MILLION)
  • FIGURE 6 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN 2D ULTRASOUND 2018-2026 ($ MILLION)
  • FIGURE 7 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN 3D & 4D ULTRASOUND 2018-2026 ($ MILLION)
  • FIGURE 8 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN DOPPLER IMAGING 2018-2026 ($ MILLION)
  • FIGURE 9 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN COLOUR DISPLAY 2018-2026 ($ MILLION)
  • FIGURE 10 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN BLACK & WHITE DISPLAY 2018-2026 ($ MILLION)
  • FIGURE 11 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN HOSPITAL & CARDIOLOGY CENTERS 2018-2026 ($ MILLION)
  • FIGURE 12 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN HOME & AMBULATORY CARE SETTINGS 2018-2026 ($ MILLION)
  • FIGURE 13 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET IN OTHER END USERS 2018-2026 ($ MILLION)
  • FIGURE 14 REGULATORY FRAMEWORKS IN CARDIOVASCULAR ULTRASOUND MARKET
  • FIGURE 15 ASIA PACIFIC CARDIOVASCULAR ULTRASOUND MARKET 2018-2026 ($ MILLION)
  • FIGURE 16 INDIA CARDIOVASCULAR ULTRASOUND MARKET 2018-2026 ($ MILLION)
  • FIGURE 17 CHINA CARDIOVASCULAR ULTRASOUND MARKET 2018-2026 ($ MILLION)
  • FIGURE 18 JAPAN CARDIOVASCULAR ULTRASOUND MARKET 2018-2026 ($ MILLION)
  • FIGURE 19 SOUTH KOREA CARDIOVASCULAR ULTRASOUND MARKET 2018-2026 ($ MILLION)
  • FIGURE 20 AUSTRALIA CARDIOVASCULAR ULTRASOUND MARKET 2018-2026 ($ MILLION)
  • FIGURE 21 REST OF APAC CARDIOVASCULAR ULTRASOUND MARKET 2018-2026 ($ MILLION)
  • FIGURE 22 CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SHARE 2017(%)
Back to Top